Generics regulatory convergence project extended to more drugs
This article was originally published in SRA
Executive Summary
The European Medicines Agency is to begin sharing its assessment reports on generic medicines with selected non-EU regulatory agencies as part of a drive to improve the efficiency of review processes and make it possible to synchronize marketing authorizations across different jurisdictions1,2.